Table 4.
Summary of Ophthalmic Sequela in Adult Brain Tumor Survivors
| Complication | Manifestation |
|---|---|
| Visual field defect: Any damage along the posterior visual pathway may result in a contralateral homonymous visual defect | Patients typically complain of vision loss, often just in the eye with the temporal visual field loss, although they may present with difficulty reading or navigating |
| Optic neuropathy: Local compression/edema may acutely lead to optic nerve injury | Decreased vision, dyschromatopsia, and visual field loss |
| Cranial nerve palsy (III, IV, and VI) | Binocular diplopia is the most common complaint |
| Dry eye syndrome: Dose-dependent; exposure of ~34 Gy cumulative radiation carries a ~5% risk of severe DES | Complaints of foreign body sensation, stinging/burning eye pain, blurry vision worsened with reading or visual tasks |
| Cataract: Dose-dependent, risk increases with as little ~2–5 Gy in one fraction | Patients will complain of gradual decreased visual acuity or glare |
| Radiation retinopathy: Dose-dependent; exposure to less than ~25 Gy cumulative radiation is unlikely to develop significant retinopathy | Patients typically complain of gradual decreased visual acuity |
| Radiation optic neuropathy: Radiation doses from 50 to 60 Gy assumes a risk of ~5% within 10 years | Characterized by painless, progressive, rapid vision loss/dyschromatopsia over several days to weeks. May present acutely or years post-exposure (peak incidence 1.5 years) |